(QQQE) Direxion NASDAQ-100 Equal - Overview

ETF Category: Large Growth | Exchange: NASDAQ (USA) | Market Cap: 1.112m USD | Total Return: 13.7% in 12m

Etf Stocks, Equities, Technology, Large-Cap
Total Rating 33
Risk 48
Buy Signal 0.04
Large Growth -3.9
TER: 0.35%
AUM: 1,112m
Avg Trading Vol: 28.9M USD
ATR: 1.74%
Peers RS (IBD): 67.1
Risk 5d forecast
Volatility19.7%
Rel. Tail Risk4.32%
Reward TTM
Sharpe Ratio0.52
Alpha-6.11
Character TTM
Beta1.103
Beta Downside1.030
Drawdowns 3y
Max DD21.38%
CAGR/Max DD0.56
Description: QQQE Direxion NASDAQ-100 Equal March 04, 2026

QQQE is an exchange-traded fund (ETF) that invests at least 80% of its assets in securities comprising the NASDAQ-100 Equal Weighted Index or investments with similar economic characteristics. This index includes approximately 100 of the largest non-financial companies listed on the NASDAQ Stock Market, equally weighted. The NASDAQ-100 primarily features companies from the technology and consumer discretionary sectors.

The fund is classified as non-diversified. This means it may invest a larger portion of its assets in a smaller number of securities, potentially increasing volatility. To further explore QQQEs specific holdings and performance, consider researching on platforms like ValueRay.

Headlines to Watch Out For
  • NASDAQ-100 component stock performance dictates fund value
  • Equal weighting strategy impacts sector exposure
  • Technology sector growth drives fund returns
  • Market capitalization shifts alter index composition
  • Interest rate changes influence growth stock valuations
What is the price of QQQE shares? As of April 01, 2026, the stock is trading at USD 98.53 with a total of 304,072 shares traded.
Over the past week, the price has changed by -0.28%, over one month by -4.85%, over three months by -3.54% and over the past year by +13.72%.
Is QQQE a buy, sell or hold? Direxion NASDAQ-100 Equal has no consensus analysts rating.
What are the forecasts/targets for the QQQE price?
ISSUER TARGET UP/DOWN
Wallstreet Target Price - -
Analysts Target Price - -